Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01116661
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain

Who this might be right for
Glioma
University of California, San Francisco 199
Early research (Phase 1)Ended earlyNCT01989052
What this trial is testing

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Who this might be right for
Malignant Glioma (WHO Grade III or IV)
Annick Desjardins 9
Not applicableLooking for participantsNCT05259605
What this trial is testing

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

Who this might be right for
GliomaGlioneuronal TumorChoroid Plexus Tumor+10 more
European Organisation for Research and Treatment of Cancer - EORTC 1,650
Very early researchActive Not RecruitingNCT05023551
What this trial is testing

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Who this might be right for
High Grade GliomaGlioblastoma Multiforme
Sumitomo Pharma America, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT03779230
What this trial is testing

Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse

Who this might be right for
Glioma of Brain
Philogen S.p.A. 20
Large-scale testing (Phase 3)Looking for participantsNCT05770544
What this trial is testing

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Not applicableStudy completedNCT05984667
What this trial is testing

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Who this might be right for
Glioma, MixedMild Neurocognitive DisorderBrain Tumor
Virginia Commonwealth University 32
Testing effectiveness (Phase 2)Study completedNCT00613093
What this trial is testing

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Glioma
Duke University 67
Not applicableUnknownNCT04689321
What this trial is testing

Revision of the EORTC QLQ-BN20 Questionnaire

Who this might be right for
GliomaBrain Metastases, Adult
Leiden University Medical Center 135
Testing effectiveness (Phase 2)Study completedNCT00003304
What this trial is testing

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 29
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07542158
What this trial is testing

Ultralow Dose PET Imaging of 18F-FDOPA

Who this might be right for
Heathy VolunteerParkinsonian SyndromesNeuroendocrine (NE) Tumors+1 more
Akiva Mintz 200
Testing effectiveness (Phase 2)Study completedNCT00005826
What this trial is testing

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 17
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Not applicableStudy completedNCT05305378
What this trial is testing

Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow

Who this might be right for
Aneurysm, AVM, Dural Arteriovenous Fistula, Glioma, Meningioma, Metastasis, Bypass
Dynamic Light 8
Testing effectiveness (Phase 2)Study completedNCT00047879
What this trial is testing

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

Who this might be right for
Glioma
National Cancer Institute (NCI) 7
Not applicableUnknownNCT06363162
What this trial is testing

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Who this might be right for
Glioma
Beijing Tiantan Hospital 200
Early research (Phase 1)Study completedNCT00002988
What this trial is testing

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 36
Testing effectiveness (Phase 2)Study completedNCT00498927
What this trial is testing

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Study completedNCT00005637
What this trial is testing

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01454596
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Who this might be right for
Malignant GliomaGlioblastomaBrain Cancer+1 more
National Cancer Institute (NCI) 18
Next Page